1345.HK Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (23 Apr 2024 @ 22:27):

China Pioneer Pharma Holdings Limited, an investment holding company, markets, promotes, and sells pharmaceutical products and medical devices primarily in the People's Republic of China...

Stats
Today's Volume	2 000.00
Average Volume	76 955.00
Market Cap	2.27B
EPS	HKD0 ( 2023-08-29 )
Last Dividend	HKD0.0480 ( 2023-05-23 )
Next Dividend	HKD0 ( N/A )
P/E	14.85
ATR14	HKD0 (0.00%)

China Pioneer Pharma Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

China Pioneer Pharma Financials

Annual	2023
Revenue:	HKD1.57B
Gross Profit:	HKD668.24M (42.65 %)
EPS:	HKD0.120

FY	2023
Revenue:	HKD1.57B
Gross Profit:	HKD668.24M (42.65 %)
EPS:	HKD0.120

FY	2022
Revenue:	HKD1.56B
Gross Profit:	HKD780.47M (50.16 %)
EPS:	HKD0.200

FY	2021
Revenue:	HKD1.43B
Gross Profit:	HKD772.03M (53.81 %)
EPS:	HKD0.120

Financial Reports:

No articles found.

China Pioneer Pharma Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
HKD0 (N/A)	HKD0.0180 (N/A)	HKD0 (N/A)	HKD0.0480 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)

China Pioneer Pharma Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 6.94 - average (97.95%) | Divividend Growth Potential Score: 2.30 - Decrease likely (54.05%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	HKD0.135	2014-05-13
Last Dividend	HKD0.0480	2023-05-23
Next Dividend	HKD0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	18	--
Total Paid Out	HKD1.227	--
Avg. Dividend % Per Year	0.00%	--
Score	2.57	--
Div. Sustainability Score	6.94
Div.Growth Potential Score	2.30
Div. Directional Score	4.62	--

Next Divdend (Est)
(2024-06-17)

HKD0 Estimate 3.51 %

Dividend Stability

0.28 Very Poor

Dividend Score

2.57

Pay Frequency

Semi-Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

With a moderate Dividend Sustainability Score (DSS), the company may sustain its dividends, but continuous monitoring is advised for any financial shifts. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for HKSE

Symbol	Title	Last dividend	Frequency	Yearly Dividend
6030.HK	Ex Dividend Junior	2023-07-03	Annually	0.00%
1818.HK	Ex Dividend Junior	2023-06-07	Annually	0.00%
0848.HK	Ex Dividend Junior	2023-05-24	Annually	0.00%
0006.HK	Ex Dividend Knight	2023-08-30	Semi-Annually	0.00%
2588.HK	Ex Dividend Knight	2023-09-25	Semi-Annually	0.00%
1382.HK	Ex Dividend Knight	2023-08-15	Semi-Annually	0.00%
0455.HK	Ex Dividend Junior	2023-06-29	Annually	0.00%
6821.HK	Ex Dividend Knight	2023-06-15	Annually	0.00%
1931.HK	Ex Dividend Knight	2023-09-04	Semi-Annually	0.00%
0966.HK	Ex Dividend Junior	2023-07-10	Sporadic	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.0930	1.500	8.14	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0952	1.200	6.83	8.19	[0 - 0.3]
returnOnEquityTTM	0.147	1.500	9.48	10.00	[0.1 - 1]
payoutRatioTTM	0.532	-1.000	4.68	-4.68	[0 - 1]
currentRatioTTM	2.50	0.800	2.50	1.998	[1 - 3]
quickRatioTTM	1.294	0.800	7.09	5.68	[0.8 - 2.5]
cashRatioTTM	0.258	1.500	9.68	10.00	[0.2 - 2]
debtRatioTTM	0.0475	-1.500	9.21	-10.00	[0 - 0.6]
interestCoverageTTM	0	1.000	-1.111	-1.111	[3 - 30]
operatingCashFlowPerShareTTM	-0.101	2.00	-0.0336	-0.0673	[0 - 30]
freeCashFlowPerShareTTM	-0.127	2.00	-0.0636	-0.127	[0 - 20]
debtEquityRatioTTM	0.0723	-1.500	9.71	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.427	1.000	6.22	6.22	[0.2 - 0.8]
operatingProfitMarginTTM	0.0852	1.000	-0.295	-0.295	[0.1 - 0.6]
cashFlowToDebtRatioTTM	-1.632	1.000	-10.00	-10.00	[0.2 - 2]
assetTurnoverTTM	1.023	0.800	6.51	5.21	[0.5 - 2]
Total Score				6.94

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	14.41	1.000	8.65	0	[1 - 100]
returnOnEquityTTM	0.147	2.50	9.67	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	-0.127	2.00	-0.0424	-0.127	[0 - 30]
dividendYielPercentageTTM	4.03	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	-0.101	2.00	-0.0336	-0.0673	[0 - 30]
payoutRatioTTM	0.532	1.500	4.68	-4.68	[0 - 1]
pegRatioTTM	-0.314	1.500	-5.43	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	-0.0758	1.000	-4.39	0	[0.1 - 0.5]
Total Score				2.30

China Pioneer Pharma

China Pioneer Pharma Holdings Limited, an investment holding company, markets, promotes, and sells pharmaceutical products and medical devices primarily in the People's Republic of China. It has a portfolio of pharmaceutical products, such as ophthalmology, pain management, cardiovascular, immunology, gynecology, gastroenterology, and other therapeutic areas, as well as medical devices, including ophthalmology, orthopedics, odontology, and wound care products. The company sells its products to hospitals and medical institutions, and pharmacies. It also sells ancillary tools and leases accessories; and sells dental devices. In addition, the company engages in the sale of imported in-licensed prescription products. China Pioneer Pharma Holdings Limited was founded in 1996 and is headquartered in Shanghai, the People's Republic of China. China Pioneer Pharma Holdings Limited is a subsidiary of Pioneer Pharma (BVI) Co., Ltd.